Dihydroberberine

Dihydroberberine is a Botanical supplement available in 1 form.

Not all forms of Dihydroberberine are equal. The form you choose determines how much Dihydroberberine actually reaches your tissues, and the difference between the best and worst forms can be substantial. Dihydroberberine is the active gut metabolite of berberine with approximately 5x greater oral bioavailability. This means equivalent clinical effects at 1/5th the dose, dramatically reducing the GI side effects (cramping, diarrhea) that limit standard berberine HCl supplementation at therapeutic doses.

Dihydroberberine Preferred (T1 Preferred) has a bioavailability rating of high (S1 — best tier). Typical dose range: not yet documented in our database.

Dihydroberberine is the active metabolite of berberine with approximately 5x greater bioavailability than standard berberine HCl. Research demonstrates equivalent clinical effects at significantly lower doses due to enhanced absorption. This reduces the GI side effects commonly associated with high-dose berberine supplementation while maintaining efficacy for metabolic health support.

Dihydroberberine demonstrated approximately 33x dose-normalized bioavailability advantage over berberine HCl in a pilot human pharmacokinetic crossover study. PMID: 35010998

Berberine phytosome (phospholipid complex) showed 3-fold improvement in plasma exposure vs standard berberine in preclinical pharmacokinetic models. PMID: 38888754

Standard berberine HCl oral bioavailability is less than 1% due to extensive P-glycoprotein-mediated efflux and hepatic first-pass metabolism. PMID: 27020531

Dihydroberberine is classified as T1 Preferred in the FormulaForge formulary — our top recommendation for Dihydroberberine. It carries a bioavailability rating of high (S1 — best tier), meaning more of the active compound reaches your tissues per dose unit compared to lower-tier forms.

When choosing a Dihydroberberine supplement, look for the S1 (best absorption) bioavailability tier on the label or formulary listing. T1 Preferred forms have the strongest research-backed evidence for efficient absorption.

Other forms may be appropriate depending on individual goals, cost considerations, and your healthcare provider’s guidance. The best form for you depends on your specific health needs.

For Dihydroberberine, the typical dosing range is not yet documented in our database. Individual dose requirements vary based on health goals, body weight, and existing nutrient intake.

Side Effects: Specific side effect data for these forms is not yet documented in our database. In general, consult your healthcare provider regarding tolerability at higher doses.

These statements are based on structure/function research and have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.

The following studies and findings inform our formulary classifications for Dihydroberberine:

Dihydroberberine demonstrated approximately 33x dose-normalized bioavailability advantage over berberine HCl in a pilot human pharmacokinetic crossover study. PMID: 35010998

Berberine phytosome (phospholipid complex) showed 3-fold improvement in plasma exposure vs standard berberine in preclinical pharmacokinetic models. PMID: 38888754

Standard berberine HCl oral bioavailability is less than 1% due to extensive P-glycoprotein-mediated efflux and hepatic first-pass metabolism. PMID: 27020531